0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Meningitis -Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-441
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Meningitis Epidemiology Forecast to 2028

Meningitis -Epidemiology Forecast to 2028

Code: DELV-Epid-441
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Meningitis - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Meningitis epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Meningitis Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Meningitis in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Meningitis outlook. It also includes the explanation of changing trends of epidemiology outlining the Meningitis scenario.

Meningitis Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Meningitis thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Meningitis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Meningitis Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Meningitis

Key assessments
• Patient Segmentation in Meningitis
• Meningitis Risk & Burden
• Factors driving growth in a specific Meningitis patient population

1. Report Introduction
2. Meningitis Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Meningitis in 2016
2.2. Patient Share Distribution of Meningitis in 2028
3. Disease Background and Overview: Meningitis
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Meningitis in 7MM
4.3. Total Prevalent/ Incident Patient Population of Meningitis in 7MM – By Countries
5. Epidemiology of Meningitis by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Meningitis
5.1.3. Sub-Type Specific cases of the Meningitis *
5.1.4. Sex- Specific Cases of the Meningitis*
5.1.5. Diagnosed Cases of the Meningitis
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Meningitis
5.4.3. Sub-Type Specific cases of the Meningitis*
5.4.4. Sex- Specific Cases of the Meningitis*
5.4.5. Diagnosed Cases of the Meningitis
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Meningitis
5.5.3. Sub-Type Specific cases of the Meningitis*
5.5.4. Sex- Specific Cases of the Meningitis*
5.5.5. Diagnosed Cases of the Meningitis
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Meningitis
5.6.3. Sub-Type Specific cases of the Meningitis*
5.6.4. Sex- Specific Cases of the Meningitis*
5.6.5. Diagnosed Cases of the Meningitis
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Meningitis
5.7.3. Sub-Type Specific cases of the Meningitis*
5.7.4. Sex- Specific Cases of the Meningitis*
5.7.5. Diagnosed Cases of the Meningitis
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Meningitis
5.8.3. Sub-Type Specific cases of the Meningitis*
5.8.4. Sex- Specific Cases of the Meningitis*
5.8.5. Diagnosed Cases of the Meningitis
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Meningitis
5.9.3. Sub-Type Specific cases of the Meningitis*
5.9.4. Sex- Specific Cases of the Meningitis*
5.9.5. Diagnosed Cases of the Meningitis
6. Unmet Needs of the Meningitis
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Meningitis in 7MM
Table 2: Total Prevalent/Incident Cases of the Meningitis in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Meningitis in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Meningitis in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Meningitis in United States (2016-2028)*
Table 6: Diagnosed Cases of the Meningitis in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Meningitis in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Meningitis in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Meningitis in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Meningitis in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Meningitis in France (2016-2028)
Table 12: Sub-Type Specific cases of the Meningitis in France (2016-2028) *
Table 13: Sex- Specific Cases of the Meningitis in France (2016-2028) *
Table 14: Diagnosed Cases of the Meningitis in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Meningitis in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Meningitis in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Meningitis in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Meningitis in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Meningitis in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Meningitis in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Meningitis in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Meningitis in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Meningitis in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Meningitis in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Meningitis in UK (2016-2028) *
Table 26: Diagnosed Cases of the Meningitis in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Meningitis in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Meningitis in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Meningitis in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Meningitis in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Meningitis in 7MM
Figure 2: Total Prevalent/Incident Cases of the Meningitis in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Meningitis in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Meningitis in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Meningitis in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Meningitis in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Meningitis in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Meningitis in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Meningitis in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Meningitis in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Meningitis in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Meningitis in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Meningitis in France (2016-2028) *
Figure 14: Diagnosed Cases of the Meningitis in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Meningitis in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Meningitis in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Meningitis in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Meningitis in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Meningitis in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Meningitis in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Meningitis in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Meningitis in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Meningitis in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Meningitis in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Meningitis in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Meningitis in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Meningitis in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Meningitis in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Meningitis in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Meningitis in Japan (2016-2028)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global and United States Sexually Transmitted Disease Therapeutics Market Report Forecast 2022 2028
Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Othe-412
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Vaccine Technologies Market Report Forecast 2022 2028
Global and United States Vaccine Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-30Z5715
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Healthcare Acquired Infection Market Report Forecast 2022 2028
Global and United States Healthcare-Acquired Infection Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24Z5686
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Viral Vector Vaccines Market Report Forecast 2022 2028
Global and United States Viral Vector Vaccines Market Report & Forecast 2022-2028

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.Market Analysis and Insights Global and United States Viral Vector Vaccines MarketThis report focuses on global and United States Viral Vector Vaccines market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Viral Vector Vaccines market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-30G10233
Tue Jun 07 00:00:00 UTC 2022

Add to Cart